-
2011 ., 7 (102)
-
2- 7 (102) 1997 .
..
:
..
.. (. . ), .. , .. (. ),
.. , .. , .. , .. , .. , ..
:
.. (. ), .. (. ),.. (. ), .. (. ),
.. (. ), .. (. ),.. (. ), .. (. ),
.. (. ), .. (. ), .. (. ), .. (. ),
.. (. )
:
050008, . , . , 66..: 8 (727) 375-80-57, 8 (727) 375-14-74. : 8
(727) 375-05-29.
E-mail: [email protected]
.
471 27.03.97.
050022, . , . , 98,
./ 260-67-08
.-. . 17,5. 701001/16
. 500 .
. ..
, 2011
-
3
.. . : ( )
.....................................................................5
.. .
..............................................................12..
, .. , .. , .. ,
.. , .. , .. , .. , .. .
.............................................................................................................16
.. .
.............................................................................................20
.. .
.................................................................24
.. , .. , .. , .. . -
.......................................................................................26
.. .
..................................................................
30
.. , .. , .. , .. .
..............................................................................................................35
.. , .. , .. .
.............................................................37
.. , .. , .. , .. , .. , .. , .. , .. . . (20002009 ..)
..........................................................................................40
.. . - 20052010
..............................................................................................................................45
.. , .P. . () -
......................................................................................................................49
.. . ....................................................51
.. . -
...............................................................................................................56
.. .
....................................................................................................................................................58
.. . ..................................61.. .
....................................................64.. .
.............................................................................................................................................67..
. ...............70.. , .. , .. , . ,
.. . ...............................................72.. .
..........................75.. . -
2010
..............................................................77..
.
2010
....................................................................................................79
.. C, .. , .. .
...................................................81.. .
.....................................................................83..
.
.................................................................86
-
4.. .
............................................................................................................88
.. . -
.......................................................................................................................................91
.. , .. . llergyscreen
...............................................................................................................94
.. . -
...............................................................................................................................96
.. .
..................................................................................................................................................99
.. .
.............................................................................................101
.. , .. , .. , .. , .. .
.............................................................................................................................................104
.. . : , , , .......106 .. .
20082010 .
..................................................................................................................110..
. - ......112.. . -
- ......................................................116.. .
-
........................................................................................................................119..
. -
........................................................................122..
.
, ............................125.. .
................................................................................................................................127..
. ............. 129.. . ...131.. . -
.................................................................
133.. . -
............................................................................................................135..
. - -
......................................................................................................................................139..
. Helicobacter pylori -
.....................................................................................................................141..
. -
........................................................................................................................143..
, . , .. , .. . -
......................................................................146..
. ...149.. , .. . --
.........................................................................151..
. - ........153.. . ...155
. . . -
....................................................................................................................158
-
5
2011, 7 (102)
618.145-007.415-053.5/.81-036.1-07-085
..
( )
. ..
, , - , - [1, 2, 3]. , - [2, 4].
-: , - ; , ; [1, 2]. , , 41,4 88,4% [1, 2, 5, 6]. 60% , -
81,688,3%, 335% [1, 2, 5]. 54% - , 24% , 4% [5]. , , , [1, 2]. - .
11,5 . , , -, , , . - [6]. () E F , , - , . , II [6]. , 4570% - , -
. [7, 8]. 12% 1113
-
654% 2021 [7, 9]. .. i, - 66,7% , 56,9%, - 9,7%, 47,2% [10]. - -
; - ; ; - [10]. .. - 5,6% [11].
- [1, 2]. - ( ), - , - . , , - - [1].
() [12, 13]. , , , 81 97% [12, 13, 14]. 80 90% -, 85 87% [1,
14]. - 2 , [15, 16, 17]. - - , -- , [14, 15, 16]. .. , [1]. ..
[10], . - [1]: 7 , ; ; - ; 510 ; - . - 70% [1, 13, 14]. - , , , 63
95% [13, 14, 15]. 48 80,6% , 13,834,0%, 16,0% 2,0% [1, 13, 14]. 1 -
, 0,3 , - - [14], 23 - , , 0,20,6 , , -
-
7 , [1].
2540% - . 1015 . - : , - ; ; [14].
[18]. ( , , - ), , ( , -), . - , . , - - . , 32,2 91,4% [12,
18].
-- () (). 96% 85,9% -. , [1]. , - , 79,2%. - - 52,6 66,8% [12].
, , , , . . - , [12].
- -- . , , - . - , , , - . - 90%, 98% 96% [1]. - 2- , - . 1- .
-
-
8 -. - - TR/TE- TR/TE-. , - 1, , , 2 [19].
- [3, 20, 21, 22]. , : , - , [21, 22, 23]. 94,997,6% [23, 24]. ,
, , , -, [24, 25], . - -: , ; - ; 10 [22, 23]. 4753% - [8]. - , -
[23]. G.D. Davis 86% , 16,6 [8]. - [5] 12 , - , , . . - - , [5]. -
. . .. , 94% [26]. .. - - [1].
- , [27]. - -125 - , , [27]. -125 - , - [27, 28]. .. , -125 100%
[28]. -
-
9 .. [27] -125 36% 12- 88% 34- . - , -. - . -125 -, -125 - [29,
30]. , -125 , , , - [29, 30].
(- , ) - : , - . , , [31]. .. .. , - , 24- - ( 23 ), 24- . - , ,
, , - [32]. - , .
, , - , - .
1. .., .., .. . .: , 2006. 416 .2. .., .., .. . .:
, 2002. 452 .3. David ., Redwine M.D. Laparoscopic approach to
the diagnosis of endometriosis.//.
: . ., 1996. . 128133.4. .. -
.// . ., 2000. . 1112.
5. .., .. . // . 1996. 5. . 812.
6. .. ().// . .. .: , 2000. . 245260.
7. Laufer M.R., Goitein L., Bush M., Cramer D.W. and Emans S.J.
Prevalence of endometriosis in adolescent women with chronic pelvic
pain not responding to conventional therapy.//J. Pediatr. Adolesc.
Gynecol. 1997. 10. P. 199202.
-
10
8. Davis G.O., Thillet E., Lindemann J. Clinical characteristics
of adolescent endometriosis.//J. Adolesc. Health. 1993. Vol. 14. P.
362368.
9. Laufer M.R., Goldstein D.P. Pelvic pain, dysmenorrhea and
premenstrual syndrome.//In: Pediatric and Adolescent Gynecology.
IVth edition. Boston, Little Brown. 1998. P. 363410.
10. i .. i ii, i i i -i ii i: . . . . , 2002. 143 .
11. .. - - : . ... . . : 14.00.01. , 2006. 27 .
12. .., .. - .// . 2000. 1. . 4853.
13. .. : . - . . ., 2005. 367 .
14. Patel M.D., Feldstein V.A., Chen D.C. at al. Endometriomas.
Diagnostic performance of US.//Radiology. 1999. Vol. 210, 3. P.
739745.
15. .. . .: , 2002. 247 .
16. .. . .//- . . .. .: , 1997. . 3942.
17. .., .., .. - . : . 1997. 111 .
18. .., .. : - . .: . 1997. 36 .
19. .., .., .., .. , - .// . 1997. 3. . 3640.
20. .. : .// . .. . .: , 2000. 32 .
21. .., .., .., .., .. - .// . 1996. 5. . 2324.
22. .., .., .., .., .., .. .//- . 1999. 4. . 2529.
23. .., .. - .//. : - . ., 1996. . 363364.
24. .., .., .., .., .. - .// -. 2000. 1. . 1923.
25. .., .. .// . 1997. 6. . 911
26. .., .., .. . - .//. - : . ., 1996. . 145146.
27. .., .., .., .. . - -125, -19-9 .// . 1995. 5. . 2528.
28. .. - , : . ... - . : 14.01.01. , 1990. 280 .
29. .., .., .., .. .// . 1995. 5. . 3537.
-
11
30. .. , -: . - . . ., 1995. 24 .
31. .., .., .. - -. , 1998. 121 .
32. .., .. - : . , 2002. 32 .
..
( )
, 4570% - . - , -, , , .
..
( )
, . .
Summary
S.M. Saduakasova
MoDERn METHoDS oF DIAGnoSIS GEnITAL EnDoMETRIoSIS JUVEnILE AGE
In GIRLS
(Review)
High information of modern research methods to diagnose
endometriosis at an early stage to estallish the location,
distribution of endometriosis, which is important for the choice of
treatment strategy, especially in yong patients.
-
12
2011, 7 (102)
616.53.2..
8, - , .
, -, . : ; - ; .
, - . , . - . , , . -. . - , . . - , . - , .
, - , . , , , - () .
, , , - .
. . , . , -. , , , , .
, , . , , , -. . , - .
, , , . - , , , .
, , . ,
-
13
, - . , , , . , , ; ; - , . , , - .
, , , . - , , , . - , , ; ; - (, , . .)
, , , . . -, , D, E.
, . , , ; , , , , . ( , , , ) . D , , , , ; , . - (, , ) (, ) .
.
-. , , 1:1:4. (1)
1 ,
(/)
,
1 2 3 4 51 6 11 2350 77 79 335
2 11 2713 90 92 383
- , - .
2
(), (),
610 1118 610 1118
1 2 3 4 51 (-) 80 120 80 1202 150 200 150 2003 15 20 15 20
-
14
2
1 2 3 4 5 64 , 45 50 45 505 15 20 15 206 250 250 188 1887 , 350
400 280 3208 () 200 200 185 1859 () , . . 15 20 15 20
10 , -, . .
200 200 200 200
11 ( ) 1 . 77 (95) 86 (105) 70 78
12 1 ( 1 . /)
40 (51) 60 (76) 35 53
13 - 60 80 58 7714 15 20 14,7 19,615 ( 2,53,2%) 300 300 300
300
16 ( 2,53,2%)
150 180 150 180
17 ( 9%) 50 60 50 6018 10 12 9,8 11,8
19 ( 15%)
10 10 10 10
20 30 35 30 3521 15 18 15 18
22 1 . 1 . 40 4023 40 45 40 45
24 10 15 10 15
25 0,4 0,4 0,4 0,426 1,2 1,2 1,2 1,2
27 1 2 1 228 5 7 5 7
- .
: - .
. 1- : (25% ) 7.30, (1520% ) 11.0012.00, (3540% ) 15.0016.00 (
20% ) 20.00.
2- : 1- 8.00, 12.0013.00, 16.00, 20.00.
-
15
3
( )
( )
6 11 11
1 2 31 (, , ,
, )150200 200250
2 (, , , , , .)
200 200
3 60100 100150
4 () 200250 250300
5 , (, ), , 80120 1001206 150200 180230
7 100 100
, . , , , -. , , . , . , , . - . .
, , , , , .
717 - - (2).
- .
1. 834 25.10.2010 . - - , . . 67, 1819.
2. .., .. . .: . . 144146.
3. .. . ., -, 2010. . 269.
..
- .
-
16
..
.
Summary
S.T. Saduova
RATIonAL nUTRITIon oF PUPILS
The article presents information about the basics of nutrition
and the organization of nutrition in schools.
2011, 7 (102)
613.6:61
.. , .. , .. , .. , .. , .. ,
.. , .. , ..
.. , .
- , [1, 2].
( , , , - , ) . , , [3]. . [4]. - (90%- ). 57,2% ( 42,8%). , -,
. [5].
-
17
, . - 40 , 36 . .
() , .
, 34 10 . 50%- 79 , 30%- 46 , 7,58,3%- 10 .
, 1030 , 42,5%- 13,9% - 2030 . .
. (50% 36,1% ) . (
-
18
. 68 . - .
42 - . . , . - 34 . . , , , . .
( ). 1 , 3 . , - .
. ,
- .
, : ?, , .
(
-
19
75% 63,6% .
, - . - , - , .
1. 18 , 2009 193-IV , 87 .
2. ( 06.01.2011 .). -, , 15 , 2007 . 251-III .
3. .. - -.// . . . : , 2007, 15 .
4. .., .. .//. 2011, 02. 5457 .
5. .. 4//http://confermedic.ru/content/view/480/79/.
.. , .. , .. , .. , .. , .. , .. , .. , ..
, , - . - .
.. , .. , .. , .. , .. , .. , .. , .. , ..
, - . .
-
20
Summary
Toguzbaeva K.K., Bekmagambetova J.D., Abdullaeva G.M.,
Seyduanova L.B.,Niyazbekova L.S., Ukibay M.S., Dauletkalieva R.J.,
Zhunistaev D.D., Saylybekova A.K.,
Umarova M.M., Nurshabekova A.B.
HyGIEnIC ASSESSMEnT oF STUDy qUALITy oF HEALTH oF HEALTH woRkERS
DUE To THE InFLUEnCE
oF THE CoMPLEx SoCIAL AnD oCCUPATIonAL FACToRS
Thus, the preliminary results of a study on the basis of a
questionnaire survey show that working conditions in conjunction
with adverse social factors can influence health providers.
However, to make decisions to improve the health of health workers
this conclusion requires a more thorough scientific approach based
on studying and assessing the incidence of health workers.
2011, 7 (102)
613.648
..
"
, - - . [1]. - - - - [2].
-, . , , - , .
- in vitro - .
. , - - [3, 4]. , -
-
21
-: , , .
. 0,1 5,0 - :
y=0,00570,3161 (R2=0,8832) ; y=0,00670,3307 (R2=0,8206) ;
y=50,50,6383 (R2=0,6321)
. -
DataFit, 5.0, . y
(D).
, , (), . - (D1, D2Dn), - - (n1, n2. ni). Di ni y
(Di). ni,
ni y
(Di). pi = ni/ni y
(D) (Di, pi). , ni,
y
(D) , , , , Do y
(D) (D
) =
y
(Do ).
y a b
0,025 0,0057 0,3161
0,34 )
-
22
y a b
0,0015 0,00005 0,638
0,26
)
y a b
0,0014 0,00005 0,638
0,14
). 1. : ) ; ) ; )
.
-
23
- . , 0,025 , - 0,34 ; 0,015 0,26 ; 0,0014 0,14 . - 0,25 (.
1).
- 0,026 , - 0,35 ; 0,028 0,32 ; 0,0011 0,13 . 0,26 .
, - , - - , .
1. Snigireva G., Shevchenko V.//Recent Research activities about
the Chernobyl nPP accident in Belarus, Ukraina and Russia. kyoto
University: Res.Reactor Institute, 2002. P. 256267.
2. .. , . . . . . . 2003, 36 .
3. Shevchenko V., Snigireva G., Fedorenko B.//The effect of low
dose radiation/Ed. E. Burlakova V. naidich. Boston: Utrecht. 2004.
P. 3049.
4. .., .., .. . .// . . 2006. . 46. 4. . 447456.
..
in vitro - .
..
in vitro - .
-
24
SummaryK.O. Makhambetov
MATHEMATICAL MoDELInG AnALySIS oF GEnETIC EFFECTS In URAnIUM
PRoDUCTIon woRkERS
The article presents the results of the study activity to study
the dependence of parameters of cytogenetic analysis in vitro and
mathematical modeling of genetic effects.
2011, 7 (102)
618.145-007.415-07..
. ..
- . - 50% [1, 2].
- [3, 5]. - , . , , - [17].
- .
. 115 , - 20092010 . 25 45 32,80,3 . 61 (53,1%) 54 (46,9%) .
5,31,2 ( 1 15 ). 1 10 ( 3,21,6 ). 22 55 ( 30,61,8 ). , - , -. , -,
, , , -. ( , ). , , -, 1821- . -
-
25
42 (36,5%) I , 38 (33,1%) II 35 (30,4%) III . 65 (56,5%) , . : ,
, ; . , - , , -- . I 46 (40%) , II 8 (6,9%). - 97 (85,2%) . , , 22
(19,1%) . 15 (13%) , 2 (1,7%) - . -. 100% . 108 (93,9%) , 7 (6,1%).
- : 1) , , ; 2) 6 . - 1 . . [1, 68]. - - 52,6%. : 1 ; 2 , -, , , ,
- . , , , - . - . 12 .
1. .. - .//. , . ., 1988. . 6975.
2. .., .., .. . ., - -, 2002. 452 .
3. .. .//, . 2004. 3. . 65.
4. .. . // , . 2009. 3. . 4749.
5. .., .. - .// -. ., 1983. . 7882.
6. Mettler L., Semm K. Three-step-therapy of genital
endometriosis.//Medical management of the endometriosis. new york:
Raven, 1986. P. 23347.
-
26
7. Thomas E.J., Cooke I.D. Successful treatment of asymptomatic
endometriosis: does it benefit infertile women. Br. Med. J.1987.
Vol. 294. P. 11171119.
..
- . -. 12 .
..
- , . . 12 .
Summary
G.J. Zhatkanbaeva
EVALUATInG THE EFFECTIVEnESS oF CoMBInED TREATMEnT oF
InFERTILITy In woMEn wITH ExTERnAL
GEnITAL EnDoMETRIoSIS
Patients with infertility and external genital endometriosis
need active treatment, regardless of the extent of its
distribution. Preference should be given a two-step treatment with
drugs antigonadotropnym in the second stage of treatment. The
optimal period of observation after treatment 12 months.
2011, 7 (102) 618.3:618.58
.. , .. , .. , ..
, , .
() . - , -- [1, 2, 3, 4].
, 6,5% - 31,1% . , , . , - 23 -
-
27
. , .
-, , , , , , - . -, - , , -, [5, 6, 7].
69 - . - : 18 8,7%; 1935 87,0%; 35 4,3%. (88,4%) . 30,4% - ,
8,7% , 21,7% , 4,3% . 47,8% - , 13% . 47,8%, 43,5%, 8,7%.
-, 13% 2227 , 56,5% 2834 , 35 30,5% . 69,6% , 30,4% - . 69,6% 9
(13%) (- , , ). 2 39,1% , 34 52,2% 4 17,4% .
, --- 69,6% , 21,7% , III . 4,3% . , 13,0% .
28 13,0% , - 2834 39,1% , 35 47,8% . 30,4% , 56,5%, 13,0% .
: 500999 13,0%; 10001499 13,0%; 20002499 46,5%.
7 (10,15%) , 1 28 , 5 2834 , .
85,7% - , , , , .
-
28
14,3% - .
62 , , 8 , (562,5%) . , , 37,5% . 217,4.
59,4% , 34,8% 5,8% . -, , - .
34,8% I 44,9% II -. 20,3% , III , .
- , . , , , , , , -; , .
, - . - , , - , .
10 50% - 78 , 67 , . - .
, -- , , , -- . - . - , , .
- - , , , , , - - .
-
29
-, .
, 59,6% 33,3% - , , , , . - , , , . 45,2% -. , .
G 20,0% 59,6% - . , - - .
: - - , -, , , . - . .
- . - III 40% - I 10% . 21,2% IIIII
, - ( III ),
, , - . - , , - .
1. .. .//. 2005. . 13. 1. . 3133.2. .. -
.// . -, 2009. 2. . 5457.
3. .. - (, ): . . -. . . , 2004. 44 .
4. ... - : . . . . . , 2006. 22 .
-
30
5. Longs A.F., Labarta J.I., Mayayo E. Children born small for
gestational age: multidisciplinary approach.//Pediatr. Endocrinol.
009. l. 6. P. 324325.
6. .., .. : - .//. . . 2007; 2: 913.
7. .., .., .., .. - , .// . ., 2008. 3. 5. 55 .
.. , .. , .. , ..
- . 69 , - . 217,4. - .
.. , .. , .. , ..
. 69 , - . 217,4 . .
Summary
G.B.Bapayeva
PERInATAL oUTCoME In FETAL GRowTH DELAy
The incidence of intrauterine growth retardation syndrome fetus
in pregnant women increases. Analysis of the 69 stories of
familiesof pregnant women showed that a delay in fetal development
is characterized by extremely adverse outcomes for the fetus and
newborn. Perinatal mortality formed 217. It is interesting to
search for new innovative methods of antenatal fetal growth
retardation correction.
2011, 7 (102)
618.145-007.415-053.5/.81-036.1-07-085
..
. ..
- , . - - . -
-
31
- , , - , , - . , - , -, 20 45% [1, 2]. , 12,246,1% - - [3, 4].
, . - 10%. , , , - , [5, 6, 7]. - , , . - , , [8]. , - .
() (-) . (-) , -, . . , - -- - [8]. () , ( , ), , . - , , - ,
.
- . , , . - , . 58 [10]. -
-
32
- . - , - -, .
. - [9]. - . - - , , - . ( - - ), . - , , , , , . , , . - -, . ,
- , [10].
-, , .
- .
. - - 60 , ( ), 50 ( ). - - .
. - (350,0%) , 40,0% (24) ,
-
33
15,0% (9) 4,0% (2) , 0,05.
70,0% (35) 48,3% (29),
-
34
4. .. - -. . . . . , 2001. 22 .
5. .., .., .. . ., , 2002. 452 .
6. .., .. . -.// - 5, 2006.
7. .. -. . . . . . . 2003. 26 .
8. Allaire C. Endometriosis and infertility: a review. J Reprod
Med. Vol. 51. 3. 2006. P. 164168.
9. .., .., ..//. .: , 2006. 416 .10. i .. i ii, i i i -
i ii i . . . . , 2002. 143 .
..
60 -- , 40,0% (24) . (18,3% - 6,0%), 15,0% (9) 4,0% (2) , 15,0%
(9) 4,0% (2) .
..
- 60 - 40% (24) . (18,3% 6,0%- ), 15% (9) 4,0% (2 ) , 15% (9)
4,0% (2) . - , 12- , 10- .
Summary
Sh.M. Saduakasova
PECULIAR PRoPERTIES oF SoMATIC HEALTH oF JUVEnILE GIRLS wITH
GEnITAL EnDoMETRIoSIS
Postnatal development of girls with endometriosis was
characterized by a high frequency of formation of extragenital
pathology, which can be explained by the formation of an immune
response by type of congenital (compensated) immunodeficiency
states and leads to the increase of chronic extragenital pathology.
Predisposition to extragenital pathology is a clinical marker of
immunodeficiency states.
-
35
2011, 7 (102)
616-002.5:618.899
.. , .. , .. , ..
, - , .
, - , - - . - 1019% - . 3764% , , , , . - 1528% , . -, 510% .
20% . - , , . - , , , , -
2010 . . 38 . - .
. - 2770% , . . - . - 96% . 14% . , . - , - .
. : - - .
. - , , - .
.
-
36
. , -. (, ) , . - - 90% .
, - .
: 1. ,
90% . 2. , -
- .
3. , , - .
. 1. L 1
. 2.
. 3. L1
. 4. L1
-
37
1. .., .., .., .., .., .. .// : , -, 2004. . 738748.
2. Vincent T. DeVita, Jr, Samuell Hellman, Steven A.
Rosenberg//Cancer Principles and Practice of oncology. Vol. 2 3rd
edition. P. 19781985.
3. Tomita K., Kawahara N. et co//Surgical Strategy for Spinal
Metastases Spine, vol. 26. no 3, 2001.
4. Tokuhashi Y., Matsuzaki H., Toriyama S., et al//Scoring
system for the preoperative evaluation of metastatic spine tumor
prognosis, -Spine, -15- 1990. pp 11101113.
5. Martin H.E., Ellis E.B. Biopsy by needle puncture and
aspiration Ann Surg. 92:139, 19307. 6. Robert Coleman, MD, FRCP.
Bone Metastases From Breast Cancer and other Solid Tumors.//
ASCo 2001, -San Franisco- May 1215-Education Book pp 152163.
.. , .. , .. , ..
.
.. , .. , .. , ..
, i i iii i .
Summary
T. atikov, . Dyussembayev, B. Izturov, A. Ilyasova
VERTEBRoPLASTy SPInE TUMoRS
After studying of the given material it is possible to offer as
a choice method through the skin vertebroplasticity with the
combined treatment of metastasises and tumoral defeats of a
backbone.
2011, 7 (102)
616 003.8:616811
.. , .. , ..
, - , .
. : ; ; , ; - . -
-
38
, - . . - 2010 . . - , .
- . 41,7 1 . . - , . -, , . , , - , .
. . 1969 . . 14.12.2010 2 . : () - . . 15.12.2010 - (Sol.
Lidokaini 1% 9 ml) - - () (. 1, 2).
. 1.
. 2.
-
39
. -. .
: , - . - . -.
, . - , .
1. Balberkin A.V., Kolondaev A.F., Baranetskiy A.L., Snetkov
D.A., Khokhrokov G.I., Samochatov D.N., Buklemishev Yu.V., Shavyrin
D.A. Limb Sparing Treatment in Tumor of Proximal Femur.//Sarcoma.
2006. Suppl. (xIx annual meeting of European Musculo-Skeletal
oncology Society). ID 246.
2. Altermatt, S. operative treatment of solitary Bone Cysts with
Trycalcium* Phosphate Ceramic/S. Altermatt, M. Schwobel, J.P.
Pochon//EurJ.Pediatr.Surg. 2007. 2. P . 180182
3. Bauer, T.W., Muschler G.F.//Clin. ortohp. 2008. 371. P.
10-27. 120. Baschang A., von Laer. Indication and Procedure of
Benign Bone Cysts in Children and
Adolescents.//Eur. J.Pediatr.Surg. 1991. 1. P. 207209.
.. , .. , ..
, . , .
.. , .. , ..
, ii i ii i. i ii , -i i i .
Summary
A.K. Dyussembayev, T.M. Tatikov, B.Zh. Izturov
APPLICATIon oF MInIMALLy InVASIVE RADIoLoGICAL oPERATIonS In
oRTHoPEDIC onCoLoGy
The offered way of the osteoplasticity, at osteoblasts can be a
choice method. The applied technique of operative treatment allows
stopping a painful syndrome, to stabilize process and to improve
qualities of life of patients.
-
40
2011, 6 (101)
616-036.22
.. , .. , .. , .. , .. , .. , .. , ..
. (20002009 .)
. , . .. , -
() , - [1]. . , 2009 ., 1,1 , , 60% - 5 . . 500 000 [2].
- , -, , - . , - [3].
.. , , . (, , . .) - [4]. , , .
, , , - . . [5, 6].
. .
. , . . 10 ( 2000- 2009 .) . .
69 20.04.2009 . -
-
41
.
- (1997), 535 22.04.1985 . () , - - , , , , . - Excel, , , -. -
t- (
-
42
, (58,87,7 57,68,4 ), , (15,12,1 19,12,6) (
-
43
2
, . 2000- 2009 .
Shi
gell
a fl
exne
ri 2
a
Shi
gell
a so
nnei
Shi
gell
a fl
exne
ri 1
a
Shi
gell
a fl
exne
ri 1
b
Shi
gell
a fl
exne
ri 6
Shi
gell
a fl
exne
ri 2
b
Shi
gell
a fl
exne
ri 3
a
Shi
gell
a bo
ydii
Shi
gell
a fl
exne
ri 3
b
Shi
gell
a fl
exne
ri 4
a
Shi
gell
a fl
exne
ri v
ar. y
Shi
gell
a fl
exne
ri 4
c
Shi
gell
a fl
exne
ri 4
b
Shi
gell
a fl
exne
ri 5
a
Shi
gell
a fl
exne
ri v
ar. x
36,
3%
21,8
%
13,5
%
8,3%
6,2%
5,8%
3,0%
2,4%
1,11
%
0,88
%
0,22
%
0,20
%
0,09
%
0,07
%
0,04
%
, - , . . , - - . -- , ( ). - .
. -. , -, -. . , -, .
1. . . 22.04.10 .
2. Diarrhoeal Diseases (Updated February 2009) Diarrhoeal
Diseases: Shigellosis. February. 2009.
3. .., .. . // ., . 1997.4. .., ., .. -
. // V - . ,1995.
5. , .. . // VII -, . 1997. . 123124.
6. .., .., .. - . // . 2002. 3.
-
44
.. , .. , .. , .. , .. , .. , .. , ..
. (20002009 .)
-
, . 2000- 2009 . 4520 . 3,80,6 10 000 . 3 . 16 , - Shigella
flexneri 2a (36%). .
.. , .. , .. , .. , .. , .. , .. , ..
(20002009)
. 2000 2009 4520 - . 10 000 3,80,6 . 3 . 16 Shigella flexnerae
2a (36%) . - .
Summary
B.T. Begeubaeva, M.V. Lankina, G.T. Seiketova, E.T. Aimurzaeva,
T.A. Kim, A.K. Ospanova, A.T. Karbuzova, A.K. Jullaeva
SHIGELLA CAUSED EnTERIC FEVER In ALMATy oVER TEn-yEAR PERIoD
(20002009)
The retrospective study of Shigella isolates collected over a
10-year period (20002009) were done. All of the isolates were
received from the feces of patients hospitalized to infectious
hospital of Almaty, kazakhstan with symptoms of acute intestinal
infection. 4 520 serotypes were identified. Enteric fever caused by
Shigella occurred all over the year. In average, 3,80,6 cases for
10,000 people of Shigella caused enteritis were bacteriologically
confirmed. Shigellas were three times more frequently detected
between June and november. Shigella serovar flexneri 2a ranked as
the most common serovar (36%). we plan to continue research for
studying biological and epidemiological characteristics of Shigella
in Almaty.
-
45
2011, 7 (102)
: 340.6_343.982.323
..
-
20052010
. - -- , - (-, , , .). -- , ; , - (), , , . - - - : ; ; - ; ( -
); ( ).
- , ( 1).
: 1) -
2005 2010 ; 2) -
;3) -
.
- 2005 2010
2005 2006 2007 2008 2009 2010 1.
36
(11,39%)30
(9,43%)43
(14,42%)34
(9,49%)21
(7,09%)41
(12,53%)205
10,71%
2.
141 (44,62%)
143 (44,96%)
143 (47,98%)
151 (42,17%)
67 (22,63%)
102 (31,19%)
747 39,04%
3.
21 (6,64%)
27 (8,49%)
14 (4,69%)
31 (8,65%)
28 (9,45%)
33 (10,09%)
154 8,05%
4.
78 (24,68%)
72 (22,64%)
50 (16,77%)
60 (16,75%)
97 (32,77%)
77 (23,54%)
434 22,68%
5. 22 (6,96%)
25 (7,86%)
36 (12,08%)
61 (17,03%)
69 (23,31%)
47 (14,37%)
260 13,59%
-
46
1 2 3 4 5 6 7 8 96.
18
(5,69)21
(6,60%)12
(4,02%)21
(5,86%)14
(4,72%)27
(8,25%)113
5,90%
7. -
316 318 298 358 296 327 1913
. - 20052010 .
1 , - : , , , , , , , , , - , 9,43% , . 2007 43 , 14,42% , .
2008 34 , 9,49% , . 2009 21 , 7,09% - , . 2010 41 , 12,53% , . -
205 , 10,71% 20052010 .
2 , -, , - - () , . , 2005 141 , 44,62% - . 2006 143 , 44,96% ,
. 2007 143 , 47,98% , . 2008 151 , - 42,17% , . 2009 67 , 22,63% ,
- . 2010 102 , 31,19% , . , , 747, 39,04% 20052010 .
3 , - , , . , , . , 2005 21 -, 6,64% , . 2006 27 , 8,49% , .
2007 14 , 4,69% , . 2008 - 31 , 8,65% , -
-
47
. 2009 28 , 9,45% , . 2010 33 -, 10,09% , . , -, 154, 8,05%
20052010 .
4 , - - . , 2005 78 , 24,68% , . 2006 72 , 22,64% -, . 2007 50 ,
16,77% , . 2008 60 , 16,75% , . 2009 97 , 32,77% , . 2010 77 , -
23,54% , . - 434 , 22,68% 20052010 .
5 -, - . , 2005 22 , 6,98% , . 2006 25 , 7,86% , . 2007 36 ,
12,08% , . 2008 61 , 17,03% , . 2009 69 , 23,31% , . 2010 - 47 ,
14,37% , . 260 , 13,59% 20052010 .
6 , , -, , . , 2005 18 , 5,69% , . 2006 21 , - 6,60% , . 2007 12
, 4,02% , . 2008 21 , 5,86% - , . 2009 14 , 4,72% , . 2010 27 ,
8,25% , - . 113 , 5,90% 20052010 .
, : 1) 2005 2010 -
, - .
-
48
2) -- , - .
3) .
, , -.
..
-
20052010
- 2005 2010 , (-) .
..
20052010 -
20052010 - - , () , .
Summary
O.B. Kim
THE RETRoSPECTIVE AnALySIS TyPE PHySICIAnoF CRIMInAL LAw ExPERT
oPERATIonS FoR 20052010
The retrospective analysis physician-of criminal law expert
operations is organized for period with 2005 on 2010, is herewith
shown sloppy track record on each type of the expert operations
(the studies) in quantitative and percent correlation.
-
49
2011, 7 (102)
340.6.. , JI.P.
() -
() , -, . - [1],
313
. 1 13 , 1 20 , 1 38 , 1 250 -, . =8,2.
. , 0,01% 0,5 1 , 0,125%, 0,25% 0,5% , . . .
[1] 100% 3050% 24 , 20% 4 . . 0,3 5 - 0,00010,0018 / [2]. -
0,075 3 8 0,00030,00035 / [3]. 25 0,025 [4], , 0,0250,027 /. [5]
0,023 /, 0,024 /, 0,086 /. 1025 .
- , . - -. 425 .
[6] -- .
- , 0,01% .
0,5 3 - 10% , 1 10% 1 - . . , .
1 10 10% . - . 1 10 1 1% 10% . 15 .
-
50
( , , ).
, , - .
[7] - 5% 10% .
- . - Sorbfil () -1 0,1 0,3; 0,6 1,2 . - - (2:3). . Rf-0,86, 0,6
1,2 , 0,3 . - 5% 10% , - .
- ( ). - , 4,2 18 - , 100 . - , .
- Sorbfil () -1 0,1 . - (2:3) - . Rf=0,86, 0,6 . , 12+kSCn ,
Rf=0,86 : 0,003; 0,03; 0,3 0,6 . - 0,003 .
: , 5%
10% - - . .
- - - , 4,2 18 () 100 . . 0,003 .
1. Clarke's. Isolation and Identification of Drugs in
pharmaceuticals, body fluids and post-mortem material. Second
Edition, London, The Pharm. Press, 1986.
2. D. Davies et al., Br. J. clin. Pharmac, 1976, 3, 348 .
-
51
3. A. Kerahen et al., Eur. J. clin. Pharmac. 1978, 13, 97101.4.
J.A. Rotellar et al., Lancet, 1981,1. 1312.5. I. Lukkari et al.,
Bull. mt. Ass. forens. Toxicol., 1983, 17(2), 1314.6. A.A. , .. ,
.. . () -
. , 1983, 4, . 3638.7. S. Goenechea and M. Franke. kokain,
Mitteilung der Senatskommission fur klinische
Toxicologische Analytik DEG (1993).
A.E. , ..
() -
, - .
.. , ..
- ()
.
Summary
A.E. Kublschkaya, L.R. Musabaeva
DETERMInATIon oF CLonIDInE (CLonIDInE) In FoREnSIC PRACTICE
The article presents data on the properties and methods of
diagnosis of poisoning caused by clonidine.
2011, 7 (102)
: 591.4:612.017.1:546.18-615.099.2
..
- . .. , .
, - , - () [1, 2, 3]. , - [4, 5, 6, 7]. [8, 9].
: -.
-
52
. 50 - 150180 . . 2 , .
(/) - . 0,1% 0,20,3 .
( 3 - , 0,5 /) . 7, 14, 21, 30- . 10% (70%, 80%, 96%, 96%, 96%)
. - 58 , -. - 2,5% 1% . - JEM-100.
. , . - , . - , -, . . , - . , .
, , . -, , , - .
7 - - , , - . . - . , , .
-
53
, , . , . , , - , . . - , . - , , , . . 21- , , . - - , , . , -
. - , . -, , , , , . , - . .
- ( -) , - . -, -, . . , . - , - . - . . .
30-
-
54
. - , , , - . , - . - . . , - .
- , - . , . , - . -. , .
- , - , . , , - . , , . -, , . -, -, , .
. , , . - - . , 8- 28,7% . - , . - - ,
-
55
. - - .
1. .., .. . , . . . . -, 1982. . 105107.
2. .. - . . . . -, 1983, 24 .
3. .. . . . . ., 1984.
4. .. - . . . . -, 1992. . 50.
5. .. . . 1994. 377 .
6. .. . - . 1994. 4. . 6264.
7. .. - - . . . . -, 1993. 40 .
8. .., .. - . , . 2, 2006. . 1316.
9. .., .., .. - . , -. . 2008. 3. . 139143.
..
- .
..
.
SummaryA.N. Temirbekov
THE STUDy oF STRUCTURAL CHAnGES In THE CEnTRAL oRGAn oF THE
IMMUnE SySTEM THyMUS
In CHRonIC ToxICITy oF PHoSPHoRIC
The article presents the results of a study of the
ultrastructural morphological changes in the thymus of chronic
poisoning with yellow phosphorus.
-
56
2011, 7 (102)
618.2
..
-
,
-- . , 20022005 7 . , [1]. , . - [24].
() -, . - 735% , . [5]. - , - . - , - [6, 7].
. - - - .
135 -, . , II : 14 , 2224 . , (), -- () . 01, ( 16 / 18) - -
().
. 27 (45%) - ( ). 33 (55%) ( ), -500000 14 per rectum : 1 12 10
(20 ), 1 12 (10 ).
: (n=45 ) , -; (n=16 ) , ; (n=14
-
57
) , . - ( , -) 3 6 ; - 1 ( , ). . .
1014 . HPV 2- . .
. - 9 (27,3%), -500000 ( ). .
, , 3 , 11,1%. 7 (25,9%), - , ( - < 50%) IgG, . , -500000 , .
- .
-500000 - - - 14 - 2,5 , . .
( , , ), 3 6 61 (81,3%) - . 18,3 . . - 8 (10,7%) , , . . .
, . - - .
1. .. - , - .//. ... ., 2005. 105 .
2. .., .. .//. 2002. . 4. 1. . 46.
3. .., .., .. . - .// . 2001. . 2. 2. . 110116.
4. .., .. : -. .: . 2002. . 352.
-
58
5. Anzivino E., Fioriti D., Mischitelli M. et al. Herpes simplex
virus infection in pregnancy and in neonate: status of art of
epidemiology, diagnosis, therapy and prevention.//Virology Journal.
2009.V. 6. 40.P. 111.
6. .., .., .. : . : , 2001. 251 .
7. .., .., .., .. - -2: .//: ., 2001, 24 .
..
-
- . - .
2011, 7 (102)
618.2..
1, .
- , . -, .
6070% - 6575% , 813 , ( .., 2005).
. , , , , - , , , , , - .
, -:
1. .2. .3. .4. .5. .6. 16 .7. , , .8. .
-
59
- :
1. .2. .3. .4. . -
, - .
- () . , , , , .
() 1- 48 , -
- .2- , -
. 3- -
. 746 21.12.2007 . -
, - - . - , .
, - ( 48 ).
. . , .
(, ).
, - , - , . 18 2433 . - 30 , 4 30 13 . 3 : (0,9 1 ), (-
-
60
24 / 3 , 8 / 45 ).
- ( 3 ) / - .
12 28 33 -, . 25 35 .
: , , , , -- .
12 , - .
- , - , , , . . 810 - . 10 15 . 15 - .
, 75% - . 16,7% -, -. 8,3% , , , - .
11 - -. 7 7- . 3 - 4- .
. - , , .
710 37,5% - 57,1% , . 1 2829 .
, . (30 /) - -
-
61
. -, , .
..
, - - . , - , .
2011, 7 (102)
618.3-008.6:616-003.96
..
5, .
() , - , . , . 6,3 . , 14% 70% - [1, 3, 4]. , , , - / ( 6872%) .
: (1824%) - ; - (1142%); (4050%), - [2, 4]. (1015%), (810%), (78%).
- - (- 12%, 2%), ( 38%) [17].
- (12 ) 46 , 1214- . - 23 23 ; 34 . Fe2+ (100 ) (60 ), .
- .
-
62
. 5 - 120 II III . . 1- 60 , II ; 2- ( ) - 60 , 3540 . II (1 ),
2- 3638 ( 1 2 ). 25 39 . 41 (68,3%) 1- 15 (25,0%) 2- , 19 (31,7%)
45 (75,0%) . -- - 15 (25,0%) 12 (20,0%) , 22 (36,7%) 15 (25,0%). 3
(5,0%) 1- 5 (8,3%) 2- . : - 12 (20,0%) 1- , 15 (25,0%) 2-; 18
(30,0%) 9 (15,0%) ; 3 (5,0%) 2 (3,3%); 25 (41,7%) 29 (48,3%) . - -
- , . , , .
. ( , , -, , , -) 14 (23,3%) 1- 32 (53,3%) 2- . 38 (63,3%) 16
(26,7%) 1- 2- ; I - 18 (24,0%) 26 (65,0%). II 14 (23,3%) 1- 28
(46,7%) 2- . III 6 (10,0%) 9 (15,0%) , - 15 (25,0%) 18 (30,0%) , 1
1- 2 2-, , - . 26 (43,3%) 38 (63,3%), 19 (31,7 %) 1- 27 (45,0%) , -
5 (8,3%) 8 (13,3%), 3 (5,0%) 5 (8,4%) . - II 2 (3,3%) 4 (6,6%) III
1 (1,6%) 3 (5,0%) . , - II III . , ; - . . - , (, , ). 1- - 48
(80,0%) 2- 52 (86,7%), -
-
63
12 (20,0%) 8 (13,3%) . 22 (36,7%) - 1- 42 (70,0%) 1- 7 , 5- 8 9
. 1- 3190,00,42, 2850,00,89 . - . , , , 2- (33%). 1- (24%). -,
.
. 1. -
. 2.
.
1. .. . 2000; 2:6:164172.2. .., .., .. . -
. 2003; 1:13:1822. 3. .. .
2002; 2:6:2227. 4. .. - --
: . . . . . , 2005; 24.
5. .., .. . . 2000; 4:2:260261.
6. .. .// , . -- 1, 2, 3. 2011. . 9495.
7. Alen L.H. Biological mechanisms that might underlie irons
effects on fetal growth and preterm birth. J nutr 2001;
131:282:581589.
..
. - .
-
64
2011, 7 (102)
618.3..
5, .
, - , - . . -, , , , . Helicobacter pylori, . , , . , - , : , ,
, , , - (, ), - , [1].
, - .
, - . ( , ) -, . , , - . - , I , 23 .
-.
. : ; . : ; .. .
, . . - , , , , , , .
-
65
( 3060 ). ( 11,5 ). I, III -
[2]. . : , -
- . ;
- . - . , . - ( ), , , . , , , . Hb - . , . ;
. . , , -, . , . , , ( , , , ). . .
. 25 ; , . . - . . - 34 .
- : - , , . . : , . - , [3].
: , ; . -
;
( ( Hb), - , ( );
Helicobacter pilori;
-
66
; pH- -
. .
. -
, , , , , , - ( - ), , - , .
- , , - . -, , . , . 35 . -, 23 . -, , 23 . - , .
, , .
( ). - .
, . , , - . , , 23 . , - [4].
1. Brandt P.A., Nielsen C.V. Job stress and adverse of
pregnancy: a causal link or recall bias?//Am. J. of Epidimiol.
1992. Vol. 135. P. 302311.
2. .. , .//. . 1995. . xxVII, . 34. . 5456.
3. .. . ., 1996. 300 .4. ./ . .. . .: --
, 2005. 880 .
..
, , - -. , , - .
-
67
2011, 7 (102)
618.3
..
1, .
- - [1, 2, 3]. -, . - , - , - [4].
, - - - -. - - , , - , , -.
- 30 - 1624 . , ; -; .
26,5 . 88,1%
. - (30,0%).
, 4 , (64,3% 15,0% ).
( , , ) - (31,4%) .
, , 34% , , . . - (57,1%) , .
-
68
, 77,85,6% - . - II (57,46,7% 20,45,5% , p
-
69
, . - . . .
, - . . . - , - .
, -, , -, .
. - : , , , , - , , , .
- 2829 1 -, ( 0,40,6 0,861,15 ).
, - 2 . - : , , . - .
, - , - . , - -, , , . , - .
:
1. .. : -. . . . , 2007, 25 .
2. .. - .//. 2002, 245 .
3. .. . ., , 2002, 144 .4. .., .. -
.// . 1990. 8. . 35.
-
70
..
, - .
2011, 7 (102)
613.2/.3..
, .
, . , , , . , , -, , , , . . , , . , .
, 50 , .. -. 15 , -. . 2002 . 48 .
, - , , , .
330 05.08.2003 . - - ( ), . , - , , , - , .
: ; ; ;
-
71
; . ,
, , , . - ( ) -- . , , , - .
1 15 , - .
- - .. .
- . , . , -, - . , , -, .
, - . - ( ), .
- , -. , , , - - . RATIonAL: Self Cooking Centr ( ) Vario
Cooking Center () - .
- . . , , - , , - .
VarioCooking Control , , , -
-
72
, , . - . , . ( , , ) - , , . , - : , , , . , - .
, - - , . , , - , .
..
- - , . , , , - .
2011, 7 (102)
618.3
.. , .. , .. , . , ..
8, 5, .
-, , - . , - , , - , - , -. , , , . -
-
73
- . - . - , . - . 25%, 1020% [1].
- -, (- -, , , . .). (8090%) : B, Staphylococcus spp., E.coli,
Proteus spp., klebsiella spp., Enterobacter spp., Bacteroides spp.,
Peptostreptococcus spp., G.vaginalis, C.trachomatis.
:) , ) ;) ;) , (-
, , ) [2]. , -
; .
:1) 34- 1012
. : 39 , , , , , . -. , .
2) 24- . - 3940 , , , - . , 9- ;
3) (57- ). 38 , , , 25- . : , ;
4) : :) 510 , -
, . - , , 35 /, , ;
) . 23- , 39 , - ( , , , , ), . , , , , -
-
74
, . .
, , , , , , , , - .
: -
; ; . 2448 . -
, - [3, 4].
, - . - , , , . , - , -, , . - , .
, , - - , - .
1. ... .. -, .. , . 10 18, 2002.
2. ./ . .. . .: --, 2005, 880 .
3. .. . .: , 2004, 120 .
4. .., . .//- . 20012002, .1, 1, . 4546.
.. , .. , .. , . , ..
, , - - - .
-
75
2011, 7 (102)
616-053.2..
16, .
- , , , , (, ), .
, .
- , .
, - .
100 , :
IG A .
. . , 12 , . . . .
. -
, . : ( -
- , ). ( , -
). ( -
). , . . -
(DHA, AR17). Iq. . ,
: (2). .
-
76
. . ,
. (-
). ,
. . : . . - (, )
. . ( 260270 /),
, . . 1993 . -
( \) 115 15.06.1997 ,
, .
( - ) (1):
1. , - .
2. , - .
3. .
4. - .
5. , - , .
6. - , .
7. , 24 .
8. , .
9. - , .10.
. ,
- , , , .
-
77
, , .
1. 115 15.06.1997 . - .
2. ./.. , . . , 2010, 17 .
..
.
2011, 7 (102)
616-053.2..
2010
7, .
() - . . - . , , .
. - , , , - . , , . , . , . - (45 ) - , - : , - , .
( ), - , - , - .
-
78
, . - - , , . [1, 2].
, - , . , . - , - , . , - , , . , , , . , - .
2010 2134 - , . - I 1462 (68,5%), II 641 (30%), III 37 (1,5%).
15, 5 , 8, 4, 8, 21, 3, 3, - 2, . 35, 1 4.
2010 2009 , - , , , , , , . 100 43,9 2009 . 42,5 2010 . , - 100
4,6 2,7; 1000 8,8 2,8 - 2009 2010 .
2010 232 , 91, 3, 10, 53, 2, 10, 5, 6, 15, 2, 4, . 35, 15, 1 4.
: 3 , 15 , 2036 , 21, 59.
, -- 2010 .
1. .., .., .. ./ : . -. , 2000, 301 .
-
79
2. - ./ . .. . ., 2006, 608 .
..
2010
- , 2010 . - .
2011, 7 (102)
616-053.2
..
2010
7, .
(69 ), (1014 ) (1517 ). , . - . , -, . , . , , . - , , , ,
-.
. - -, , , , - . . , , . - - -. , . .
-- . - , ,
-
80
. , , -- , -, - , . . - . -, , , , . , , - . - , . , 15- - . .
15 15 . - 14 112, 14 026 025.
2010 12 703 . I 3921 (30,9%), II 7745 (61%), III 1014 - (8%),
III 23 (0,2%). 129 , 39, - 121, 12, 152, 81, 25, 163, 5, - 12 9
.
2010 2009 , - , 3783 3547 , - , , , , -, - , , . 1000 188 2009 .
181 2010 . , 8 3.
2010 73 , 130 3441 , .
, -- 2010 .
1. .., .., .. ./ : . -. , 2000, 301 .
2. - ./ . .. . ., 2006, 608 .
-
81
..
2010
- , - 2010 .
1000 188 2009 . 181 2010 . , 8 3.
2011, 7 (102)
616-053.2
.. C, .. , ..
. .. , .
() -, , . 1990- . - , , , , , , , , . , , 5 , , , 2 () 2 5 .
- , , . . - , 37,5 . - , 37,5 , , , - . , , , , , . , 5 , , - :
3 . - , , , , . ( , , , ) , -
-
82
, 38,5 . , - , - . 50 , 7,5 /. , 6 , 1 5 . - 45 10- .
5 , - 38,5 , .
, , , . 38,5 , - . , , 25 / 1 , 2 3 5 ; 2 3 , -1 - 600 000 .
, - , , , 2 , - . , 2 3 1 (120 5 ) 3 5 2 (10 ) ( 500 ). , - , ,
, , , , , .
3 , - , , ; ; . 3 , . , - (), - .
, - ( ). : , , , 2 . , - ; 5% 1% - . , -, 6 ; -; 12
-
83
; , . - . , , , .
3 , . . , , : 6 50 000 , 6 12 100 000 , 12 5 200 000 .
, - , .
1. (): 2 5 79 .
.. C,, .. , ..
, - ; ; , ; -; , . - , .
2011, 7 (102)
616-053.2
..
7, .
. - , . , . - , -, . , , - . - . 1,52 . , .
-
84
, . , .
- . , 1,52 , 4050 . , . 510- , , - , . . - . .
. 4050 . , 40 , - , .
. , - . , .
, . - , - . , . - , , , , - , . ., . , .
. , , - ( ).
. , - , . , , , - . ( 7580) - , . , . - . - . . - , , .
. - . - , -
-
85
. , , . . - . - , . , -, , . 8 , , , , . 12 , . , - , .
- . - . .
.. , - .
1. ; , .2. .
, . . .
3. -. , , - .
4. , . - , .
, () , , - , .
1. .. . ., , 1995.2. .., .., .. ./ : . -
. , 2000, 301 .3. - ./ . .. .
., 2006, 608 .
..
, -, , . , - , .
-
86
2011, 7 (102)
616-053.2..
7, .
, , . -, , . , . , , , - . . , - .
, , , - , - . - 4 . 8.00 8.30, 7.30; () , - 11.30; 14.3015.30 ,
, , . . 19.30. , 14.00, - : 8.30, 12.0013.00, 16.30; 19.30. ; -
.
: 14 , , -. . - . . , , . , , . . - 3- , 6- . 15 , 30 . - . . ,
, , , , , 2 , , . : , - , .
. , -- . . , , .
-
87
. , - . , , - , - .
, . , , , , . . -, , - , ; - ; . , , , .
, , - ( , ).
, . -, - , -. (. . , , . .) , , .
, , - , , . - , , - .
( 50 ) , , -. . - , . .
, , - . . - , . , , . (, ), . , , , , .
1. .., .. .2. .., .. .3. .., .., .. ./ : . -
. , 2000, 301 .4. - ./ . .. .
., 2006, 608 .
-
88
..
, , - , . , , .
2011, 7 (102)
616-053.2..
, . ,
- , 10 - , - (, , - ). , 44,9% 614 .
() - .
-. . , , , . : , -, . . - ( ), .
( , , ). - . , (pica chlorotica), , - , , - . - .
- . 70% . (, ..), -. , IgA -.
- -. , , , , , -, , ( ) . .
-
89
, - .
, - . , , . ( ) , - , - . .
: , ; ; ; ; (); (); . : ; ();
. : Hb 11091 /; Hb 9071 /; Hb 7051 /; Hb 50 / . :1- : , -
. 1,52 . : 3 35 //; 3 7 100120 /; 7 200 /.
2- : , . - 36 . : 3 12 //; 3 7 5060 /; 7 50100 /.
3 : , . 710 , , -- 710 , 4060 /.
. - . , , - ; (, ), .
(III) - () , , . - , .
-
90
, .
:
; ; ; . (III) -
( ) () (). .
: , - , . . , 7 , , - .
, . - ( ). 14 6 13 . - , 52% . 80% , . - . 88%, 71,3%, - 67%, /
34%, 22%, 15%. - . - 88%. , 25%.
5059 / 15%, 60 / 85% 2,22,410,12/. . , - 84% . , 9,6%. , 6,3
/.
/ 34 , - . , , , , - -. .
17% 3 -, 5 83% . - . .
, - -
-
91
. - , , - .
1. .. , 2011. . 2447.2. .., .. . 2007. 28.3. .., .., .. -
. 2006. . 1317.4. .. . .
2005. . 4550.5. .. . 2007. . 38.
..
. - - . , .
2011, 7 (102)
616-053.2..
7, .
(-, , -). : , ; - . : , , , , , , , . , . , , . - - . . - , - .
-
-
92
. 1 . - 2 . -. 1 .
. - , , , . - . , - , 3 2 , 1 . , 312 , 1 , 1 3 2 , 3 , - 2 . ,
-, ; . 1 . , , , . , - - ; ; ; - . - , . , , , - . , - -- ( 5 )
.
, 23 12 . - (2 ).
, - . - . : 1 , - 2 . : , ( ). - - 3 .
- . : , ( ) 23 . , -, . -
-
93
, . - : . , - . , , . - : -, , , . , -. - , 1 . -- 2 . , . - , ,
, . - 1 3 , 1 6 . - 23 . - 1 . - . .
1. .. . ., 2003. . 1. 832 ., . 2. 736 .2. .., .. -
., 2005, 154 .3. .. -
. ., 2005, 55 .
..
, - . - .
-
94
2011, 7 (102)
616-056.3.. , ..
LLERGYSCREEN
, .
- . - , , , . - . -, , , - [1]. , . , , 1 . - 100 000 - 2008
38,3 42,3 2009 , 10,4 [2]. c , . - ( - ) , [3].
llergyScreen in vitro - . ( - , , 250 , , , , ), , [4].
- llergyScreen - .
. 2011 . llergyScreen 117 - 5 66 . 78 , 12, 17, 25, 5 .
4 : 1 , , , ;2 , , , ;3 ;4 , , . 1 44 , 243 , -
321, 49 . 6 :
-
95
0 (0,000,34 IU/ML); 1 (0,350,69 IU/ML);2 (0,703,49 IU/ML);3
(3,517,49 IU/ML);4 (17,549,9 IU/ML);5 (50,0-100,0 IU/ML);6 ( 100,0
IU/ML). 2 . ,
58 (49,5%) , 21 (17,9%), - 18 (15,3%), 18 (15,3%) . 21 (17,9%) 0
1 , - , ( ). - , - , .
(82%) -- , , - , .
, llergyScreen - - , , - ( ). -, - .
1. .., .. -.// . 2004. 12. . 1719.
2. .. , , 2011 .3. Kersten, von Wahl, in vitro comprarison of
the CLA System (Mast) and the CAP System.
Internist. Praxis 38.4. Kersten, von Wahl, Lange, C.E. Wenning,
J. (2000) Empfehlungen zur in vitro Diagnostik
allergischer Erkrankungen Allergologie 23/6.
.. , ..
LLERGySCREEn
llergyScreen 117 5 66 , 78 , 12, 17, 25, 5 . (82%) - , , , .
-
96
2011, 7 (102)
616.211.615.5 (075.8)..
6, .
- . 57 [1]. - - , --. , . , - [13].
, -, . , - , , , -, , , .
- , -, . , , , -. - , , , - .
. - . , - . , , , , (, ), . , - . , - () , .
- -, . -- (-
-
97
, , ). , .
- . . , - . , . - , , - , -, . - [4].
.
. ( URGo, ) .
. 53 : 12 , 14 , 15 , , 5 , 7 . 1 16 . . - 3 2 . .
, 26 , - 27 . .
3 . - 1 15 150 , 15 150 . - . 4 ( 2 3 ). () - , . , ( ).
- .
. ,
3-, 7- 14- . (, , , (, -) , (, - ).
. - , , , .
-
98
. , - , -. 14 . C , , -, : 23- , , . - (14- ) . , , - , 68- , -
1214 .
, , , . , , , , , - .
. - -. (- ) , .
1. .., .. . (. . 1), 2001. 1. . 45.
2. Sinus and Allergy Health Partnership. Antimicrobial treatment
guidelines for acute bacterial rhinosinusitis. otolaryngol Head
neck Surg 2000; 123 (Suppl.):. . 132.
3. Pankey G.A., Gross C.W., Mendelsohn M.G. Contemporary
diagnosis and management of sinusitis. Pennsylvania 1997, 150 .
4. .., .., .. . - . , 2008. 87(1). . 120124.
..
- . - .
-
99
2011, 7 (102)
616-053.2
..
,
- . - 10 2 . 75,682% (1).
, - 10 . , , , - .
: E. coli 53% ( 41,383,3%) Proteus spp. 8,5% Enterococcus spp.
8,5% k. pneumoniae 8,0% Enterobacter spp. 5,7% P. aeruginosa 5,4%
Staphylococcus spp. 3,7% 7,2% -
. - (2).
, - , , .
- .
- : , , -, , , -, .
, , , , - , , , .
1,5 2 .. , -, , .
45 -, . . , , , .
-
100
: ; ; ; -, .
(1): - . . . . . . . ( ; -
, ).
( , ): 7 500700 , 710 7001000 , 10 1,01,5 .
- . - , , - , , .
- (- 14 ).
- 14 , 14 6 .
: (, , ), 2 3- -, , - , ().
(3): 6 ,
36 .
3 19 , - . 16 - .
1. .., .., .. . ., 2006, 66 .
2. .. . - . . ., 2009. 36 .
3. .., .. - . - . . , 2004, 24 .
-
101
..
. - , .
2011, 7 (102)
616-053.2..
8, .
, - 90% . - [1].
, , . - , [2].
, - [3]. , , .
. 25 , 2 . 15 7 14 , (, , ) 1 (50 ) 1 1 . 10 , - , .
I II . -. - .
. - : 710 0,2230,055 /, 1114 0,2320,045 /, (0,250,60 /) , -, - ,
[4].
1 , - . , , - : (4,90,17), (5,30,22),
-
102
1
,
(n=10)
(n=15)
(109/) 5,550,39 5,70,22 0,1 5,60,22 5,70,14 0,1
% 2,67 0,21 2,7 0,19 0,1 2,9 0,12 2,4 0,18 0,1
. 0,270,02 0,250,01 0,1 0,250,01 0,240,01 0,1
.
% 3,00,37 3,00,18 0,1 3,10,19 2,80,16 0,1
. 0,140,03 0,150,01 0,1 0,140,02 0,150,01 0,1
.
% 510,79 50,60,62 0,1 51,40,6 52,40,47 0,1
. 2,70,18 2,730,11 0,1 2,910,1 2,850,07 0,1
% 4,80,28 4,60,21 0,1 4,90,17 5,30,22** 0,01
. 0,330,02 0,310,01 0,1 0,340,02 0,360,02 0,1
% 39,40,94 39,90,63 0,1 39,00,68 47,90,48*** 0,001
. 2,60,08 2,40,11 0,1 2,60,01 3,20,08*** 0,001
: *
-
103
1 2 3 4 5 6 7 (CD
4/CD8 )
1,20,01 1,30,5 0,1 1,20,1 1,90,05*** 0,001
34,90,5 371,8 0,1 34,30,6 54,22,3*** 0,001
4,40,1 4,80,2 0,1 4,50,4 7,10,4** 0,01
- % 16,51,8 171,5 0,118,51,1 21,61,6 0,1
. 0,40,01 0,410,06 0,40,01 0,390,19
Ig / 0,90,2 1,50,2 0,1 0,90,1 2,40,05* 0,05Ig / 1,30,2 1,50,8
0,1 1,20,3 1,50,7 0,1
Ig G / 9,81,4 9,91,5 0,1 9,40,1 12,70,01* 0,05: *
-
104
2011, 7 (102)
.. , .. , .. , .. , ..
. .. , .
. - malnutrition -. -- - . , . - .
() , , -, , . , -, . - , . , , - - .
, - . , -, , .. , , . , - , , , , , , - , , . : , , , . , . , ,
-, , , , , .
, - : . - , ; , ; (1, 6, 12) - , .
25 : 1 4 - 3 3 7 . .
-
105
23 , - , I , . 3- (, ), - DS: , , , - , -. , 1 10 .
(), - - (, , ), (, , , , , , ).
2- 12 (48%), 3- 6 (24%), 7- 6 (24%), 1 (4%). - , , , , - ( ). 1
17 ( 68% ), 1,5 5 (20%), 2 1 (4%). 4%. , 4- , ( ), - .
5 , I , . 1214 , 23 .
: .
1. .. : , 5- . . ., 2003. 832 ., 736 .
2. - ./ . .. . ., 2006. 608 .
.. , . , .. , .. , ..
25 : 1 4 3 3 7 . .
23 , , ; 1 , ; , .
-
106
25 1 3- . 23 72% , - 1 68% . .
2011, 7 (102)
616.9
..
: , , ,
7, .
- , , - . - - [1]. , 6 , [2]. , 90% [3]. , , 200 - 4 - (-, -, -,
) 2 - (- -). . - , (, ), , , [4].
, - , , , .
. , - , : , . , . , , , , . , - , , , , , [5]. . . . . , , ,
.
. -. 56-
-
107
. , , 23 .
. , , 23 ( 11,5 2050% ). - 36 , , 23 25% . , .
, - , - , . .
. 4,6 , . 714-. , 25% . - . - , (, , - . .). , [6].
5 : I ; II , , - ; III - ; IV ; V .
0 48 - : (, ); , , - ; . , , . , , , , . . , - ( 3840 ) . . , (
- ), , , , , , .
, - , , . - . . - , , . . , .
- ( ,
-
108
, ), 12 . - . - , , -, , .
, . , - . , , . , , . - , , : , . ., .
1030% , 538% , 35% ; , [7].
-. , , -, . . 35% . . - - . . , ( 5- ) 1214 . 4 . , -, .
: , - , , , , . : 1) ; 2) ; 3) ; 4) - . - , . 48 [8]. - , , , ,
, ., , , . .
, , - .
: , -, ; : , , , -, , 1, 2, 3, , , 0,25%; : , ; : -, , ; .
-
109
() III, IV IV / (710 ) [9].
, , -. , : , , , -, . - , .
1. .. .// . 2004. 4 (8).2. .., .., .. .//
. . 2002. . 224.3. .. -
.// . 2004. . 3. 4. . 112114.4. .., .., .. . -
.//. -. 2007. 1. . 1721.
5. .., .. .// . 2007. 8. . 1621.6. .., .., .. . - -
.// 2002. . 10. 20. . 37.
7. .. (.). . ., 2003. 1040 .
8. .. , . . ., 2002, 15 .
9. .., .., .. . , - (H1n1 SwL: , , . . 28. ., 2009, 18 .
..
: , , ,
(, , , ).
, - , . -, . -, .
-
110
2011, 7 (102)
616-002.5 (574.51)
..
20082010 .
, . ,
. , , - . . - .
( -) ( ) , - . 34,0% (1003 2949). - 200820092010 . 1003 , .
1
2008 .
1824 2534 3544 4554 55 >
. % . % . % . % . % . %
. 22 61,1 42 64,6 51 77,2 51 75,0 42 68,8 159 53,7. 14 38,9 23
35,4 15 22,8 17 25,0 19 31,2 137 46,3 36 100 65 100 66 100 68 100
61 100 296 100
2
2009 .
1824 2534 3544 4554 55 >
. % . % . % . % . % . %
. 22 68,7 53 68,8 66 76,7 54 78,3 51 63,7 246 71,5. 10 31,3 24
31,2 20 23,3 15 21,7 29 36,3 98 28,5 32 100 77 100 86 100 69 100 80
100 344 100
-
111
3
2010 .
1824 2534 3544 4554 55 >
. % . % . % . % . % . %
. 19 55,9 49 62,0 70 78,6 65 84,4 54 63,5 256 70,5
. 15 44,1 30 38,0 19 21,4 12 15,6 31 36,5 107 29,5
34 100 79 100 89 100 77 100 85 100 363 100
, 1003 3 661 (65,9%), 342 (34,1%). - 3544 , , - , 3,6 , . - :
65,9% 19,8%, 100% , - - .
- , .
4
20082010 .
S-
. % 2008 2009 2010
176 212 231 618 61,5
15 15 23 53 5,4
-
101 105 103 309 30,9
1 1 0,1
1 5 1 7 0,7 5 1 6 0,6 1 1 3 5 0,5 , -
1 1 0,1
1 1 2 0,2: 296 344 363 1003 100
4 , - 61,5%, 2- - 30,9%, 5,4%. - 176 2008 231 2010 .
-
112
1003 , 867 (86,4%), 14 (13,6,0%) . - 150 (14,9%), 236 (23,5%) R,
- 107(10,6%), 212 S (21,1%).
-: 137 (13,7%), - 184 (18,2%), 113 (11,8%), 103 (10,2%), 124
(12,3%), - 97 (9,2%).
1. .. . . . . . . ., 2006, 24 .
2. .., .. . . V . ., 1998. . 100102.
3. .., .., .., .., .. , . .//. 2010. 2 (17).
4. .., .., .. .//. 2003. 1 (3). . 97100.
5. .. : -. . . . . ., 2004. 22 .
..
20082010 .
20082010 . , - , . - .
2011, 7 (102)
616.211.615.5 (075.8)..
-
5, .
- . , - 40% - (13). .
-
113
, . - , . -, . , - . , , . - , , . , - .
. 90% - , , -. , , , - . - . , 1987 - .. , (4). . , - .
150 ( Laboratories URG, ). 150 , . 150 - : Mg ; I naCl ; Zn Se ,
. .
. , . - , - . , , , . :
, , ;
, , , - ;
-
114
, -, , ( ), ;
.
150, , - : 150 450 .
--, , . - , , . - . - , - , .
-. . . n , -, , - .
. - .
. 68 , 7 12 (38 30 ). - : ( ), ; . , . , - , 10- , 1 , - 10 .
.
-: , . , - , . 4- : 0 ; 1 ; 2 ; 3 .
2 : (35 -) (33 ). : 2 4 , - , 1 4 . -
-
115
. .
. - 68 . , , , . , 5- - (>0,05). 10- - , .
, - 5- 4,81,3 6,31,6 (
-
116
7. Bernstein J.M., Dryja D., Murphy T.F. Molecular typing of
paired bacterial isolates from the adenoid and lateral wall of the
nose in children undergoing adenoidectomy: implications in acute
rhinosinusitis.//otolaryngol. Head. neck. Surg. 2001. Dec. 125(6).
. 593597.
..
-
- .
2011, 7 (102)
616.1
..
-
.
(), [1]. - . , , , [25].
, ( , , - , , ) , - [7]. , - , - [8].
[9, 10].
- - , , 20 . , - 2 , 2- . 10 10 , (73,01,83) . 13 . 20 , 7 . 25
. - - - : I , - (); II ,
-
117
(). : , , - ( , ); , - . : 10 . 3/ 30 . 3 . - : 1 . /, 3 /. ( 10
).
- , 12, 10, -, , .
, - ( 50 2 /, 40 2 /, 10 2 /, 12,5 ).
- 20 .
. : - () () ( Meditech (-40), ); ( (), - () kem well, ). - : , ,
- ( , ), ; 5- , - , [9].
- t- .
- . , (), ( ) - , - . , - , , , II ,
, (II ) - , - . : 20 60% , , , 60% . ,
-
118
1 ( 70% - 2 , 20% ).
, - , , . , - . - , , - - , , . , - , ( ) - , - - .
, - -, , , -, , .
1. .. - .// . .: , 1985. 84 .
2. .., .., .., .. - - .// . 2000. 1. . 1926.
3. .. : . . . . . 2006. 133 .
4. .., .. - .// / . .., .., .. , , 2002. . 6371.
5. .., .. .// ./ . .. . .: -, 2007. . 160180.
6. .., .., .. . - .//- . 1997. 1. . 5156.
7. .. .// (, -, )./ . . .. . : , 2004. . 134164.
8. .., .., .. . -. ., 1995 260 .
9. .., .., .. . - : . . . - , . ., 1983. 69 .
10. ., . , - , .// . 1999. 1. . 58.
-
119
..
-
- (, , ) - - (). , 2 - , .
2011, 7 (102)
616.1
..
.
() - , , , , .
1040%, . () 1772 % [13].
, , . Hildrum B. et al. 2,06 [4]. , - - . kokubo y. et al. - -
1,75 [95% I, 1,272,41] 1,9 [95% I, 1,312,77] [5].
Thorn L.M. et al. - 2 . 10 - 6,3%, 2,7% (p
-
120
, - 2009 : : (-) 80 94 . : ( 130/85 . . .), - () ( 1,7 /), ( )
(
-
121
- , () - , , , , , . .
, .
. - 17,5% 21,0% . - () 53,5%, II ( II) 2,0%, 69,7%, () 15,2%, -
() 9,1%, 12,1%. - 65,7%, II 3,0%, 65,1%, - () 15,1%, () 12,0%,
12,0%. - . 15,7% , - 35,4% (=0,02). 43,3% 48,6% .
, , , - 63,6%. - 70 77,8%. - , , , , , , , , , . , - .
1. . ., . . .// -. 2003. 3. . 3238.
2. .., .., .. - - .// . . . 2003. 12(2). . 8083.
3. Buchanan T.A., Xiang A.H., Peters R.K. et al. Preservation of
pancreatic beta-cell function and prevention of type 2 diabetes by
pharmacological treatment of insulin resistance in high-risk
Hispanic women. Diabetes 2002;51:2796803.
4. Kokubo Y. et al. The Seventh Report of the Joint national
Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure: the JnC 7 report. JAMA 2003; 289:
25602572.
5. Thorn L.M. et al. Physical activity and diabetes
complications in patients with type 1 diabetes: The finnish
diabetic nephropathy (FinnDiane) study. Diabetes
Care31(2):230-232.
6. Hildrum B, Mykletun A, Dahl AA, Midthjell k. Metabolic
syndrome and risk of mortality in middle-aged versus elderly
individuals: the nord-Trndelag Health Study (HUnT). Diabetologia.
2009 Apr;52(4):58390.
7. Ninomiya J.K., LItalien G., Criqui M.H., et al. Association
of the metabolic syndrome with history of myocardial infarction and
stroke in the Third national Health and nutrition Examination
Survey. Circulation. 2004; 109:4246.
-
122
..
, , - , - 70 . - .
2011, 7 (102)
616.61..
-
,
() -- , - - . - , , 1520% . . , 23- 45% , 100: 100 000. , , -
1015% . 8% [32]. [16, 27], 15%, 57 , .
- , (. . , ) [4]. , 40%, 3 , [5].
- - , - . 80% - , . , , .
- . - - , .
-
123
, - , . , , . (8:1), , . - - , .
, , ( -, , ) 9598% . , .
, . 3245% - . .
. . .
. - 270 .
. 270 , .
